Search

Background: Cancer diagnosis based on machine learning has become a popular application direction. Support vector machine (SVM), as a classical machine learning algorithm, has been widely used in cancer diagnosis because of its advantages in high-dimensional and small sample data. However, due to the high-dimensional feature space and high feature redundancy of gene expression data, SVM faces the problem of poor classification effect when dealing with such data. Methods: Based on this, this paper proposes a hybrid feature selection algorithm combining information gain and grouping particle swarm optimization (IG-GPSO). The algorithm firstly calculates the information gain values of the features and ranks them in descending order according to the value. Then, ranked features are grouped according to the information index, so that the features in the group are close, and the features outside the group are sparse. Finally, grouped features are searched using grouping PSO and evaluated according to in-group and out-group. Results: Experimental results show that the average accuracy (ACC) of the SVM on the feature subset selected by the IG-GPSO is 98.50%, which is significantly better than the traditional feature selection algorithm. Compared with KNN, the classification effect of the feature subset selected by the IG-GPSO is still optimal. In addition, the results of multiple comparison tests show that the feature selection effect of the IG-GPSO is significantly better than that of traditional feature selection algorithms. Conclusion: The feature subset selected by IG-GPSO not only has the best classification effect, but also has the least feature scale (FS). More importantly, the IG-GPSO significantly improves the ACC of SVM in cancer diagnostic. [ABSTRACT FROM AUTHOR]

In this paper, the classification of the two binary bioinformatics datasets, leukemia and colon tumor, is further studied by using the recently developed neural network-based finite impulse response extreme learning machine (FIR-ELM). It is seen that a time series analysis of the microarray samples is first performed to determine the filtering properties of the hidden layer of the neural classifier with FIR-ELM for feature identification. The linear separability of the data patterns in the microarray datasets is then studied. For improving the robustness of the neural classifier against noise and errors, a frequency domain gene feature selection algorithm is also proposed. It is shown in the simulation results that the FIR-ELM algorithm has an excellent performance for the classification of bioinformatics data in comparison with many existing classification algorithms. [ABSTRACT FROM AUTHOR]

Cancer is one of the fearful diseases found in majority of the living organism, which is one of the demanding focuses for scientist towards 20th century. There were bunch of proposal from a variety of establishers and detailed picture examination was still under processing. The main aim of microarrays is hybridization between two DNA strands, the property of balancing nucleic acid series to particularly pair with each other by forming hydrogen bonds between complementary nucleotide base pairs. This paper presents a fast and efficient classification technique called the Fast ELM algorithm is used for a multicategory cancer diagnosis problem according to the microarray data is supplied. ELM provides significant classification results compared to other classifiers because of its unique features. Moreover, the drawbacks of ELM are effectively dealt by using ELM as classifier. When the dataset is large, the usage of ELM will take more time for execution. For this purpose, this approach uses Levenberg Marquadt algorithm for training which speeds up the training process. In this paper, ELM is integrated with the ANP approach for finding the weighted matrix. This would enhance the performance of the overall system. [ABSTRACT FROM AUTHOR]

Leukemia is a malignancy that affects the blood and bone marrow. Its detection and classification are conventionally done through labor-intensive and specialized methods. The diagnosis of blood cancer in children is a critical task that requires high precision and accuracy. This study proposes a novel approach utilizing attention mechanism-based machine learning in conjunction with image processing techniques for the precise detection and classification of leukemia cells. The proposed attention-augmented algorithm for blood cancer detection in children (A2M-LEUK) is an innovative algorithm that leverages attention mechanisms to improve the detection of blood cancer in children. A2M-LEUK was evaluated on a dataset of blood cell images and achieved remarkable performance metrics: Precision = 99.97%, Recall = 100.00%, F1-score = 99.98%, and Accuracy = 99.98%. These results indicate the high accuracy and sensitivity of the proposed approach in identifying and categorizing leukemia, and its potential to reduce the workload of medical professionals and improve the diagnosis of leukemia. The proposed method provides a promising approach for accurate and efficient detection and classification of leukemia cells, which could potentially improve the diagnosis and treatment of leukemia. Overall, A2M-LEUK improves the diagnosis of leukemia in children and reduces the workload of medical professionals. [ABSTRACT FROM AUTHOR]

Background: Breast cancer (BC) is one of the most common cancers among women. Since diverse features can be collected, how to stably select the powerful ones for accurate BC diagnosis remains challenging. Methods: A hybrid framework is designed for successively investigating both feature ranking (FR) stability and cancer diagnosis effectiveness. Specifically, on 4 BC datasets (BCDR-F03, WDBC, GSE10810 and GSE15852), the stability of 23 FR algorithms is evaluated via an advanced estimator (S), and the predictive power of the stable feature ranks is further tested by using different machine learning classifiers. Results: Experimental results identify 3 algorithms achieving good stability ( S ≥ 0.55 ) on the four datasets and generalized Fisher score (GFS) leading to state-of-the-art performance. Moreover, GFS ranks suggest that shape features are crucial in BC image analysis (BCDR-F03 and WDBC) and that using a few genes can well differentiate benign and malignant tumor cases (GSE10810 and GSE15852). Conclusions: The proposed framework recognizes a stable FR algorithm for accurate BC diagnosis. Stable and effective features could deepen the understanding of BC diagnosis and related decision-making applications. [ABSTRACT FROM AUTHOR]

Simple Summary: The rapid development of technology has enabled numerous applications of artificial intelligence (AI), especially in medical science. Histopathological assessment of tissues remains the gold standard for diagnosis of gastrointestinal (GI) cancers for subsequent management. In a traditional anatomical pathology (AP) laboratory, histopathologists are required to manually assess, quantify and classify diseases under a microscope in a semiquantitative or qualitative manner. The conversion of analogue-to-digital pathology is on the rise, conforming with trends toward digitalization. The rapid adoption of digital pathology (DP) is driven by factors such as the worldwide shortage of pathologists and medical technologists, the increasing incidence of cancer and the critical need to improve laboratory efficiency. In this review, we aim to provide a comprehensive summary of algorithms for AI detection and classification of GI cancer. We will also provide critical insight into the application of algorithms for routine care in clinical practice. The implementation of DP will revolutionize current practice by providing pathologists with additional tools and algorithms to improve workflow. Furthermore, DP will open up opportunities for development of AI-based tools for more precise and reproducible diagnosis through computational pathology. One of the key features of AI is its capability to generate perceptions and recognize patterns beyond the human senses. Thus, the incorporation of AI into DP can reveal additional morphological features and information. At the current rate of AI development and adoption of DP, the interest in computational pathology is expected to rise in tandem. There have already been promising developments related to AI-based solutions in prostate cancer detection; however, in the GI tract, development of more sophisticated algorithms is required to facilitate histological assessment of GI specimens for early and accurate diagnosis. In this review, we aim to provide an overview of the current histological practices in AP laboratories with respect to challenges faced in image preprocessing, present the existing AI-based algorithms, discuss their limitations and present clinical insight with respect to the application of AI in early detection and diagnosis of GI cancer. [ABSTRACT FROM AUTHOR]

• Early prediction for mammography. • To diagnose the breast cancer at the earliest to reduce the mortality rate. • This paper proposes an expert system for the diagnosis of breast cancer disease using DE-RBF-KELM method. • The proposed method is effectively classifying the abnormal classes of mammograms. Breast cancer disease is a major public health problem among women worldwide. This article proposes an expert system for the diagnosis of breast cancer disease based on an evolutionary algorithm known as Differential Evolution (DE) of a Radial-Based Function Kernel Extreme Learning Machines (RBF-KELM). In the structure of the RBF-KELM, there are two adjustable parameters of the RBF-kernel which are the penalty parameter C and the RBF-kernel's parameter (σ). These parameters play a major role in the efficiency of RBF-KELM. In this study, the optimal values of these parameters have been obtained using a differential evolution (DE) algorithm. To validate the effectiveness of the suggested approach, DE-RBF-KELM was examined on the two datasets: The Mammographic Image Analysis Society (MIAS) and the wisconsin breast cancer database (WBCD) and the results were satisfactory compared to conventional approaches. [ABSTRACT FROM AUTHOR]

Purpose: Accurately delineating clinical target volumes (CTV) is essential for completing radiotherapy plans but is time‐consuming, labor‐intensive, and prone to inter‐observer variation. Automating CTV delineation has the benefits of both speeding up contouring process and improving the quality of contours. Recently, auto‐segmentation approaches based on deep learning have achieved some improvements. However, unlike organ segmentation, the CTV contains potential tumor spread tissues or subclinical disease tissues, resulting in poorly defined margin interface and irregular shape. It is not reasonable to directly apply the deep learning segmentation algorithms to CTV tasks without considering the unique characteristics of shape and margin. In this work, we propose a novel automatic CTV delineation algorithm based on deep learning addressing the unique shape and margin challenges. Methods: Our deep learning method, called RA‐CTVNet, segments the CTV from cervical cancer CT images. RA‐CTVNet denotes our automatic CTV delineation algorithm based on deep learning with Area‐aware reweight strategy and Recursive refinement strategy. (1) In order to process the whole‐volume CT images and delineate all CTVs in one shot, our method is built upon the popular 3D Unet architecture. We further extend it with robust residual learning and squeeze‐and‐excitation blocks for better feature representation. (2) We propose area‐aware reweight strategy which assigns different weights for different slices. The core is adjusting model's attention to each slice. (3) In terms of the trade‐off between providing performance improvements and meeting the limitations of GPU memory, we exploit a new recursive refinement strategy to address margin challenge. Results: This retrospective study included 462 patients diagnosed with cervical cancer who received radiotherapy from June 2017 to May 2019. Extensive experiments were conducted to evaluate performance of RA‐CTVNet. First, compared to different network architectures, RA‐CTVNet achieved improvements in Dice similarity coefficient (DSC). Second, we conducted ablation study. The results showed that compared to the backbone, area‐aware reweight strategy increased DSC by 3.3% on average and recursive refinement strategy further increased DSC by 1.6% on average. Then, we compared our method with three human experts. Our RA‐CTVNet performed better than two experts while comparably to the third expert. Finally, a multicenter evaluation was conducted to verify the accuracy and generalizability. Conclusions: Our findings show that deep learning is able to offer an efficient framework for automatic CTV delineation. The tailored RA‐CTVNet can improve the quality of CTV contours, which has great potential for reducing the burden of experts and increasing the accuracy of delineation. In the future, if with more training data, further improvements are possible, bringing this approach closer to real clinical practice. [ABSTRACT FROM AUTHOR]

The current research study is concerned with the automated differentiation between histopathological slides from colon tissues with respect to four classes (healthy tissue and cancerous of grades 1, 2 or 3) through an optimized ensemble of predictors. Six distinct classifiers with prediction accuracies ranging from 87% to 95% are considered for the task. The proposed method of combining them takes into account the probabilities of the individual classifiers for each sample to be assigned to any of the four classes, optimizes weights for each technique by differential evolution and attains an accuracy that is significantly better than the individual results. Moreover, a degree of confidence is defined that would allow the pathologists to separate the data into two distinct sets, one that is correctly classified with a high level of confidence and the rest that would need their further attention. The tandem is also validated on other benchmark data sets. The proposed methodology proves to be efficient in improving the classification accuracy of each algorithm taken separately and performs reasonably well on other data sets, even with default weights. In addition, by establishing a degree of confidence the method becomes more viable for use by actual practitioners. [ABSTRACT FROM AUTHOR]

Gastric cancer is the third leading cause of cancer-related mortality worldwide and despite advances in prevention, diagnosis and therapy, it is still regarded as a global health concern. The efficacy of the therapies for gastric cancer is limited by a poor response to currently available therapeutic regimens. One of the reasons that may explain these poor clinical outcomes is the highly heterogeneous nature of this disease. In this sense, it is essential to discover new molecular agents capable of targeting various gastric cancer subtypes simultaneously. Here, we present a multi-objective approach for the ligand-based virtual screening discovery of chemical compounds simultaneously active against the gastric cancer cell lines AGS, NCI-N87 and SNU-1. The proposed approach relays in a novel methodology based on the development of ensemble models for the bioactivity prediction against each individual gastric cancer cell line. The methodology includes the aggregation of one ensemble per cell line using a desirability-based algorithm into virtual screening protocols. Our research leads to the proposal of a multi-targeted virtual screening protocol able to achieve high enrichment of known chemicals with anti-gastric cancer activity. Specifically, our results indicate that, using the proposed protocol, it is possible to retrieve almost 20 more times multi-targeted compounds in the first 1% of the ranked list than what is expected from a uniform distribution of the active ones in the virtual screening database. More importantly, the proposed protocol attains an outstanding initial enrichment of known multi-targeted anti-gastric cancer agents. [ABSTRACT FROM AUTHOR]

The classification of breast cancer patients is of great importance in cancer diagnosis. Most classical cancer classification methods are clinical-based and have limited diagnostic ability. The recent advances in machine learning technique has made a great impact in cancer diagnosis. In this research, we develop a new algorithm: Kernel-Based Naive Bayes (KBNB) to classify breast cancer tumor based on memography data. The performance of the proposed algorithm is compared with that of classical navie bayes algorithm and kernel-based decision tree algorithm C4.5. The proposed algorithm is found to outperform in the both cases. We recommend the proposed algorithm could be used as a tool to classify the breast patient for early cancer diagnosis. [ABSTRACT FROM AUTHOR]